Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 434 entries
View as:

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03794349 Org: User:
Start: 07/08/19 End: 04/07/26 Due: 04/07/27

Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01553162 Org: User:
Start: 04/30/12 End: - Due: -

A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor

Phase: N/A Priority: Normal
NCT ID: NCT04939597 Org: User:
Start: 05/10/22 End: 09/30/27 Due: 09/30/28

Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00056069 Org: User:
Start: 12/31/02 End: 03/31/10 Due: 03/31/11

Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00499616 Org: User:
Start: 10/08/07 End: 06/30/21 Due: 06/30/22

Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00372593 Org: User:
Start: 08/31/06 End: 09/30/20 Due: 09/30/21

Studying Genes in Samples From Younger Patients With Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01585376 Org: User:
Start: 04/30/12 End: 05/31/16 Due: 05/31/17

Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00470275 Org: User:
Start: 05/31/07 End: 12/31/13 Due: 12/31/14

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00436852 Org: User:
Start: 01/31/07 End: 03/30/15 Due: 03/30/16

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01366157 Org: User:
Start: 05/31/11 End: 05/31/16 Due: 05/31/17

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

Phase: N/A Priority: Normal
NCT ID: NCT00736749 Org: User:
Start: 07/17/08 End: - Due: -

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00068419 Org: User:
Start: 02/29/04 End: 04/26/10 Due: 04/26/11

Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002618 Org: User:
Start: 12/31/94 End: 09/30/06 Due: 09/30/07

Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01273090 Org: User:
Start: 05/31/11 End: 10/31/13 Due: 10/31/14

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00690469 Org: User:
Start: 06/02/08 End: - Due: -

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00335556 Org: User:
Start: 06/30/06 End: - Due: -

Protein Expression in Samples From Young Patients With Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01426945 Org: User:
Start: 11/30/11 End: - Due: -

Gene Expression Profiles to Categorize Wilms Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00897637 Org: User:
Start: 02/29/04 End: - Due: -

Music Therapy Video Development in Improving Communication, Emotional Distress, and Recovery in Adolescents/Young Adults Undergoing Treatment for High-Risk Cancer and Their Parents

Phase: N/A Priority: Normal
NCT ID: NCT01556256 Org: User:
Start: 04/23/12 End: 10/02/23 Due: 10/02/24

Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00003790 Org: User:
Start: 02/28/95 End: 09/30/06 Due: 09/30/07

Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01544569 Org: User:
Start: 03/31/12 End: - Due: -

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00002995 Org: User:
Start: 08/31/97 End: 01/31/11 Due: 01/31/12

Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00085176 Org: User:
Start: 05/31/04 End: 01/31/11 Due: 01/31/12

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00025259 Org: User:
Start: 09/30/02 End: - Due: -

Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging

Phase: N/A Priority: Normal
NCT ID: NCT00445718 Org: User:
Start: 07/31/01 End: 01/31/13 Due: 01/31/14